secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2026-03-11T23:59:59+00:00
Accession:  0001522767-26-000027
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed reports FY2025 revenue of $159.8M, net loss widens to $14.5M, adjusted EBITDA down to $16.9M
--------------------------------------------------------------------------------

- FY2025 revenue $159.8M, up from $157.7M in FY2024; Q4 revenue $41.7M vs $38.9M.
- GAAP net loss $14.5M in FY2025 vs $12.4M; Non-GAAP adjusted EBITDA $16.9M, down from $19.3M.
- Wholesale revenue increased 11%; distribution reached 85% of dispensaries in core markets.
- Betty's Eddies ranked #1 edible in MA, MD, DE, IL; restructured Series B debt, extending maturity 4.6 years.
- CEO cites growth drivers for 2026: Delaware adult-use, Maine brand licensing, new Columbus OH dispensary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276726000027/0001522767-26-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276726000027/mrmd-20260311.htm
  HTML page:      https://secwatch.observer/filing/0001522767-26-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer